SMI Vantage Ltd
SGX:Y45
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SMI Vantage Ltd
SGX:Y45
|
SG |
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
US |
|
Heineken NV
AEX:HEIA
|
NL |
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
US |
|
SJW Group
NYSE:SJW
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Y45's stock price target?
Not Available
Y45 doesn't have any price targets made by Wall Street professionals.
What is SMI Vantage Ltd's Revenue forecast?
Projected CAGR
74%
For the last 13 years the compound annual growth rate for SMI Vantage Ltd's revenue is -17%. The projected CAGR for the next 5 years is 74%.